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Abstract
Background Pulse pressure variation (PPV) and stroke
volume variation (SVV) are dynamic preload variables that
can be measured noninvasively to assess fluid
responsiveness (FR) in anesthetized patients with
mechanical ventilation. Few studies have examined the
effectiveness of predicting FR according to the definition of
FR, and assessment of inconclusive values of PPV and SVV
around the cut-off value (the ‘‘grey zone’’) might improve
individual FR prediction. We explored the ability of
noninvasive volume clamp derived measurements of PPV
and SVV to predict FR using the grey zone approach, and
we assessed the influence of multiple thresholds on the
predictive ability of the numerical definition of FR.
Methods Ninety patients undergoing general surgery
were included in this prospective observational study and
received a 500 mL fluid bolus as deemed clinically
required by the attending anesthesiologist. A minimal
relative increase in stroke volume index (:SVI) was used to
define FR with different thresholds from 10-25%. The PPV,
SVV, and SVI were measured using the Nexfin device that
employs noninvasive volume clamp plethysmography.
Results The area under the receiver operator
characteristic curve gradually increased for PPV / SVV
with higher threshold values (from 0.818 / 0.760 at 10%
:SVI to 0.928 / 0.944 at 25% :SVI). The grey zone limits of
both PPV and SVV changed from 9–16% (PPV) and 5–
13% (SVV) at the 10% :SVI threshold to 18–21% (PPV)
and 14–16% (SVV) at the 25% :SVI threshold.
Conclusion Noninvasive PPV and SVV measurements
allow an acceptable FR prediction, although the reliability
of both variables is dependent on the intended increase in
SVI, which improves substantially with concomitant
smaller grey zones at higher :SVI thresholds.
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Re´sume´
Contexte La variation de pression diffe´rentielle (VPD) et
la variation de volume d’e´jection (VVE) sont des variables
de pre´charge dynamiques qui peuvent eˆtre mesure´es de
fac¸on non invasive afin d’e´valuer la re´ponse liquidienne
(RL) chez les patients anesthe´sie´s sous ventilation
me´canique. Peu d’e´tudes ont examine´ l’efficacite´ de
pre´dire la RL selon la valeur pre´de´termine´e
d’interruption du traitement, et l’e´valuation de valeurs
non concluantes de VPD et de VVE (la « zone grise »)
pourrait ame´liorer la pre´diction de la RL individuelle.
Nous avons explore´ l’utilisation de la me´thode a` volume
impose´ (« volume clamp method ») pour les mesures non
invasives de la VPD et de la VVE afin de pre´dire la RL en
utilisant l’approche de zone grise, et nous avons e´value´
l’influence de plusieurs seuils sur la capacite´ pre´dictive de
la de´finition nume´rique de la RL.
Me´thode Quatre-vingt dix patients subissant une
chirurgie ge´ne´rale ont e´te´ inclus dans cette e´tude
observationnelle prospective et ont rec¸u un bolus
liquidien de 500 mL lorsque l’anesthe´siologiste en
charge a juge´ le bolus e´tait ne´cessaire d’un point de vue
clinique. Une augmentation relative minimale de l’indice
de volume d’e´jection (:IVE) a e´te´ utilise´e pour de´finir la
RL avec diffe´rents seuils allant de 10 a` 25 %. Les VPD,
VVE et IVE ont e´te´ mesure´s a` l’aide d’un dispositif
Nexfin qui se fonde sur une ple´thysmographie a` volume
impose´ non invasive.
Re´sultats La surface sous la courbe ROC a
progressivement augmente´ pour la VPD et la VVE avec
des valeurs seuils plus e´leve´es (de 0,818 / 0,760 a` 10 %
:IVE a` 0,928 / 0,944 a` 25 % :IVE). Les limites de zone
grise de la VPD et de la VVE ont change´ lorsqu’on a
atteint le seuil de 10 % :IVE (de 9-16 % et 5-13 %,
respectivement) et au seuil de 25 % :IVE (de 18-21 % et
14-16 %, respectivement).
Conclusion Les mesures non invasives de la VPD et de la
VVE permettent de pre´dire de fac¸on acceptable la RL, bien
que la fiabilite´ de ces deux variables de´pende de
l’augmentation pre´vue de l’IVE, qui s’ame´liore
conside´rablement avec des zones grises concomitantes
plus petites a` des seuils plus e´leve´s d’:IVE.
Determination of perioperative fluid responsiveness (FR),
i.e., predicting whether cardiac output (CO) increases in
response to fluid administration, has been extensively
studied in the past decade.1 Dynamic (preload) variables
that rely on heart-lung interactions during volume-
controlled mechanical ventilation2 have been shown to be
good predictors of FR.1,3-5 Pulse pressure variation (PPV)
and stroke volume variation (SVV) are the most well-
known and validated dynamic variables1 and are usually
derived by waveform analysis. Noninvasive hemodynamic
monitoring devices, such as the Nexfin (or its successor,
the ClearSight monitor; Edwards Lifesciences, Irvine,
CA, USA), provide continuous measurements of arterial
blood pressure and dynamic variables using volume clamp
plethysmography.6-8 Multiple studies have shown that
these noninvasively derived dynamic variables are as
reliable as their invasively derived counterparts in
predicting FR.9-11
One specific cut-off value of a dynamic variable is
usually defined to distinguish fluid responders from non-
responders. The use of such a ‘‘binary’’ analysis may often
be inappropriate, especially considering different patient’s
comorbidities and clinical conditions. This problem may be
partially overcome using a ‘‘grey zone’’ approach,12-14
which identifies a range of values of dynamic variables
where its predictive ability is inconclusive and where
subsequent guidance of fluid administration must be
directed according to traditional clinical signs (e.g.,
comorbidity, fluid ‘‘history’’, and hemodynamic variables
such as blood pressure and heart rate).
Furthermore, substantial differences exist in the
literature1 regarding the chosen numerical definition of
FR, which is a limitation both in comparing results from
different studies investigating FR as well as in translating
individual study results into clinical decision-making
algorithms.
The aim of this prospective observational study was to
determine the effectiveness of noninvasive PPV and SVV
measurements obtained with the volume clamp device to
predict FR using the grey zone approach. Secondly,
because of the differences in thresholds for defining FR
in the literature, we investigated the prediction of FR by
PPV and SVV for a wide range of definitions of FR.
Methods
The local Medical Ethics Committee approved this
prospective observational study in April 2011
(METc2011.052; University Medical Center Groningen,
University of Groningen, Groningen, Netherlands), and
written informed consent was obtained from the study
participants. Adult patients undergoing various types of
surgery (Table 1) under general anesthesia were included
in the study if the following criteria were met: tracheal
intubation was performed, mechanical ventilation was
applied in a volume-controlled mode, and administration
of a fluid bolus was deemed necessary by the attending
anesthesiologist for clinical reasons (e.g., clinical signs of
hypovolemia or anticipated blood loss). Patients were not
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included in the study if they had cardiac arrhythmia or if
they underwent surgical procedures associated with altered
intrathoracic or intra-abdominal pressure (e.g.,
laparoscopy, open-chest conditions).15
General anesthesia was induced using propofol with either
sufentanil or remifentanil. Anesthesia was maintained with a
target-controlled infusion of propofol or with sevoflurane in
combination with a target-controlled infusion of sufentanil or
remifentanil. Tracheal intubation was facilitated by the
administration of rocuronium, and repeated doses of
neuromuscular blocking agents were administered only if
deemed necessary. Patients received 1-3 mLkg-1hr-1 of
crystalloid solution as baseline maintenance fluids according to
our standard intraoperative management.
Volume-controlled mechanical ventilation (C 8
mLkg-1 lean body mass) was performed with an
inspired oxygen fraction of 0.3-0.4, with the respiratory
rate adjusted to maintain normocapnia (end-tidal CO2 =
34-41 mmHg).
The Nexfin finger cuff was attached to the middle
phalanx of the patient’s left or right hand.
A comprehensive description of the technology behind
the Nexfin (and ClearSight) volume clamp technique has
been reported previously.16,17 In short, the finger cuff
pressure is adjusted to keep the arterial blood volume of the
finger – measured by plethysmography - at a constant level
(i.e., volume clamping). By using a high-speed feedback
loop at 1,000 Hz, the cuff pressure is adjusted to keep the
arterial wall ‘‘unloaded’’, and the cuff pressure reflects the
arterial blood pressure. An algorithm (Physiocal) is
designed to ascertain the ‘‘unloaded state’’, which regularly
compensates for any changes in vasomotor tone that might
influence the pressure–volume relationship between the
finger cuff and the arterial blood volume. A five-minute
time period was allowed to attain maximal vascular
unloading of the finger and for calibration of the Nexfin.
After this period, continuous data recording was started and
baseline values were determined just prior to fluid bolus
administration. Also, a heart reference system, which
corrects for hydrostatic pressure differences between the
finger and the level of the heart, was used for continuous
adjustment of the pressures to the level of the right atrium.
All measurements were performed in a hemodynamically
stable phase during maintenance of anesthesia and at least 20
min after anesthesia induction. By placement of opaque tape on
the monitor screen, the attending anesthesiologist was blinded
to all Nexfin data other than blood pressure. All patients
received a standardized single infusion of 6% hydroxyethyl
starch solution 500 mL (Voluven, Fresenius, Bad Homburg,
Germany) over a five to ten-minute period. No changes in
ventilator setting, table positioning, anesthetic levels, or
vasoactive medications were made in a 20-min time period
before data recording.
Hemodynamic data were recorded continuously and
subsequently extracted using Nexfin@PC software
(BMEYE, Amsterdam, Netherlands; Edwards
Lifesciences, Irvine, CA, USA). All data were then
imported into Microsoft Excel 2010 (Microsoft,
Redmond, WA, USA) and plotted for visual inspection
and removal of obvious artifacts. The data were then
synchronized and pooled. Retrospectively, to provide an
assessment of preoperative health status, the New York
Heart Association Functional Classification and the
Metabolic Equivalent Task score were also estimated.
Statistical analysis
Statistical analysis was performed using Microsoft Excel
2010, PASW Statistics 18 (SPSS Inc, Chicago, IL, USA),
and R software. The distribution of variables regarding
patient characteristics and hemodynamic variables was
assessed for normality using the Lilliefors test. Parametric
data (Lilliefors test P[0.05) were expressed as mean (SD)
and non-parametric data (Lilliefors test P \ 0.05) were
expressed as median [interquartile range; IQR]. Categorical
data were expressed as number of patients (%). A 30-sec
median was calculated for all hemodynamic variables prior
to the start and after the end of fluid administration. The
paired Student’s t test was used to compare hemodynamic
variables before and after fluid administration.
The correlation between both PPV and SVV and the
percentage change in SVI was depicted in a scatter plot and
coefficients of determination (R2) were calculated.
For each 5% step increase in SVI threshold (abbreviated
as :SVI) throughout the range of 10-25%, patients were
split into groups of fluid responders and non-responders.
Receiver operator characteristic (ROC) analysis was
performed for all thresholds, and areas under the ROC
curve (AUROC) were calculated. To give more robust
estimates of AUROC values and grey zone limits, the data
were bootstrapped in order to limit the influence of outliers.
Bootstrapping was performed by creating 1,000 ROC
curves per :SVI threshold and per dynamic variable (PPV,
SVV). R software was used for bootstrapping, and ROC
curves were generated using the ROCR software package,
and a mean ROC curve was then calculated per :SVI
threshold.18,19 DeLong methodology was applied to test for
differences between these ROC curves using the pROC
package. For the interested reader, the technique of ROC
curve calculation from bootstrapped data is further
discussed in the online Electronic Supplementary Material.
The grey zones were calculated over the bootstrapped
data as previously described12 using two methods: 1) by
calculating the range of values for which sensitivity and/or
specificity is \ 90% (‘‘inconclusive’’ results) and 2) by
calculating the 95% confidence interval around the
Noninvasive PPV and SVV at Multiple Thresholds 1155
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calculated optimal threshold for determining FR. These
optimal thresholds were calculated using the Youden index
which equals sensitivity ? specificity - 1. One Youden
index was calculated per bootstrap sample. In accordance
with the original publication of the grey zone approach,12
the widest obtained grey zone interval obtained by one of
these methods was selected as the final grey zone. At the
moment of study design, no data on different SVI
thresholds were available upon which to base the sample
size calculation. Therefore, the sample size was calculated
to ensure that at least a 10% increase in SVI - which is the
lowest SVI threshold – could be detected. Pilot
observations in our institution revealed a mean SVI of 37
mLm-2 prior to fluid bolus administration. In order to
allow a two-sided paired Student’s t test to detect a 10%
change in SVI (with an a set at 0.05 and a b set at 0.10), we
calculated that at least 82 patients should be included. We
chose to include 90 patients in order to account for possible
dropouts.
Results
Measurements were performed in 90 patients, nine of
whom were excluded for further analysis because of either
new cardiac arrhythmia (n = 3, which interferes with
accurate measurements of PPV and SVV) or technical
difficulties with data recording (n = 4, insufficient
waveform quality; n = 2, failure of the data collection
system).
Patient characteristics (n = 81) are shown in Table 1.
The median [IQR] duration of fluid bolus infusion was
385 [315-529] sec. In addition, the median [IQR] tidal
volume was 10.9 [10.1-11.7] mLkg-1 of lean body mass.
In terms of the hemodynamic response to fluid
administration, the mean (SD) heart rate was 68 (15)
beatsmin-1 before fluid administration and 67 (14)
beatsmin-1 in the 30 sec following the end of fluid
administration (P = 0.469), while the mean arterial pressure
increased from 75 (15) mmHg to 81 (17) mmHg (P \
0.0001). The SVI increased from 40 (11) mLm-2 to 45
(10) mLm-2 (P\0.0001). The mean (SD) relative change
of SVI after fluid administration was 16 (12)%, with a
range of -11 to 46%.
Mean (SD) PPV and SVV were 14 (7)% and 12 (6)%,
respectively, before volume expansion and 7 (4)% and 6
(3)%, respectively, thereafter (P\ 0.0001). The relative
change in SVI was correlated with PPV and SVV with an
R2 value of 0.41 and 0.39, respectively; P \ 0.0001
(Fig. 1).
As for the influence of the FR definition on the
predictive value, the mean ROC curves and mean [99%
confidence interval (CI)] AUROC values for the
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Fig. 1 Scatter plot of the percentage change in stroke volume index
(DSVI) after fluid administration and the associated values of PPV
(red circles) and SVV (green circles) before the start of fluid
administration. PPV = pulse pressure variation; SVV = stroke volume
variation
Table 1 Main characteristics of the patients
Sex
Male 41
Female 40
Age (yr) 52 (15)
Height (cm) 174 (9)
Weight (kg) 80 (15)
ASA class
I 32
II 39
III 10
NYHA Functional Classification
1 69
2 10
3 2
4 0
MET Score
1-4 9
4-8 53
[8 19
Taking antihypertensive medication 16
Surgical procedure
Ophthalmic 38
Neurosurgical 22
Abdominal 6
Other 15
Data are presented as mean (SD) or as absolute numbers
ASA class = American Society of Anesthesiologists physical status
classification; NYHA Functional Classification = New York Heart
Association Functional Classification; MET Score = Metabolic
Equivalent of Task Score
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investigated :SVI thresholds are shown in Fig. 2A for PPV
and in Fig. 2B for SVV. For PPV, the AUROC values of
all investigated :SVI thresholds were significantly different
from each other (P\ 0.0001), except for the difference
between the PPV values at the 10% and 15% :SVI
threshold (P = 0.654). For SVV, all investigated AUROC
values were significantly different from each other (P\
0.0001). The original ROC curves, from which the mean
ROC curves were derived, are shown in the online
Electronic Supplementary Material.
In addition, values of sensitivity and specificity for
predicting FR at the investigated :SVI thresholds are
shown in Fig. 3A-B for PPV (A) and SVV (B).
The grey zone limits of all investigated :SVI threshold
values (horizontal lines) for PPV (A) and SVV (B) are
displayed in Fig. 3. The grey zone limits of the PPV and
SVV changed from 9-16% and from 5-13%, respectively,
at the 10% :SVI threshold and from 18-21% and 14-16%,
respectively, at the 25% :SVI threshold. Table 2 further
summarizes the grey zone limits of both dynamic variables.
In addition, the number of responders and non-responders
per :SVI threshold are shown together with the percentage
of patients having a PPV or SVV value below, within, or
above the grey zone.
Discussion
We found that the ability of noninvasively derived PPV
and SVV measurements to discriminate between fluid
responders and non-responders improved substantially for
larger :SVI thresholds, which was also reflected by
narrower grey zone limits at the higher thresholds. This
finding suggests that fluid (non-)responsiveness can be
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Fig. 3 A-B Graph showing the sensitivity (dashed curves) and
specificity (solid curves) of the PPV (3A) and SVV (3B) to predict
increases in stroke volume (:SVI) after 500 mL fluid administration,
n = 81. In addition, the range of the grey zone (dashed horizontal
lines) of the PPV and SVV are shown for the different :SVI
thresholds. The small dashed horizontal line at sensitivity / specificity
of 0.9 shows the intercepts of the grey zone limits for the different
:SVI thresholds. PPV = pulse pressure variation; SVV = stroke
volume variation
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Fig. 2 A-B ROC curves for the prediction of fluid responsiveness for
PPV (2A) and SVV (2B), n = 81. Shown are the mean ROC curves
and the AUROC values together with the associated 99% confidence
intervals for the investigated :SVI thresholds. AUROC = area under
the receiver operator characteristic curve; PPV = pulse pressure
variation; ROC = receiver operator characteristic; SVI = stroke
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predicted with more certainty with a larger increase in SVI
vs a more subtle increase in SVI. These results can be used
clinically to improve guidance of fluid therapy and to
identify an appropriate threshold for defining FR if a
clinical algorithm is designed with FR and dynamic
variables as a treatment goal.
In a meta-analysis on the ability of PPV and SVV to
predict FR, the mean (SD) threshold to predict FR was 12.5
(1.6)% for PPV and 11.6 (1.9)% for SVV.1 Nevertheless,
the definition of FR varies widely. The influence of the
height of the definition of FR on the prediction of FR was
not investigated in this meta-analysis, and other studies
investigating this subject are also lacking. Generally, a
:SVI cut-off value of 10-15% is regarded as an optimal
threshold for predicting FR in most clinical settings.1
Multiple studies have investigated the ability to predict FR
by dynamic variables using the grey zone analysis, mostly
with a threshold for defining FR set at around an equivalent
10-15% :SVI threshold. This yields a grey zone at about 9-
14%, with 25% of patients with PPV or SVV within this
range.12,13,20-22 The grey zone limits we observed in this
study were comparable at these equivalent :SVI
thresholds, although the proportion of patients with PPV
and SVV values within these limits was larger (40-50%).
Interestingly, the limits were narrower at the 20% and 25%
:SVI threshold, and most importantly, the proportion of
patients with either PPV or SVV within these limits
decreased (Table 2).
The different :SVI thresholds also show marked
differences with respect to sensitivity and specificity, e.g.,
the 25% threshold is associated with a good ability of PPV
and SVV to predict FR, especially reflected by a high
sensitivity (Fig. 3). In contrast, at the 10% threshold, both
variables have only a moderate ability to predict FR (lower
sensitivity), yet with a higher specificity (Fig. 3).
The differences between FR thresholds and their
adequacy to predict FR may be partly a mathematical
consequence applicable to dynamic variables derived from
any monitoring device. Also, physiologic variation in SVI
may account for the decreased sensitivity at lower
thresholds, as more patients will be false positively
identified as fluid responders.
Still, it is important to keep these different thresholds in
mind when defining FR for implementation in a clinical
decision-making algorithm as well as in the design of
future clinical studies.
Clinically, it remains up to the anesthesiologist to decide
the extent to which an increase in CO is deemed necessary
in the individual patient and, more importantly, whether
inadvertent hypovolemia or fluid overload should be
avoided.23 For example, in a critically ill patient at risk
for pulmonary edema, it may be more deleterious to
administer fluids inappropriately. In contrast, in a patient
with a significant aortic valve stenosis, hypovolemia would
be deleterious. In the first case, the clinician should favour
a high specificity (and thus a higher :SVI threshold), while
in the second case, a high sensitivity should be favoured
(with a lower :SVI threshold). These data strongly suggest
that the observed PPV or SVV value in an individual
patient will be more conclusive for higher thresholds.
Concisely stated, PPV or SVV values below the limits of
the grey zone indicate that fluid should not be
administered, while values above the limits of the grey
zone strongly suggest that the patient will benefit from fluid
administration. For patients with PPV or SVV values
within the grey zone, the decision whether or not to
administer fluid will then be dominantly determined by
patient comorbidity or other individual clinical factors, as
the PPV or SVV value can be regarded as inconclusive.
Recent insights have resulted in a dramatic reduction in
the use of synthetic colloids, and we would not advocate
systematically administering colloids to treat hypovolemia.
Our conclusion on the use of PPV and SVV primarily
addresses the prediction of FR, which is equally applicable
to FR with crystalloids, although larger volumes may be
necessary to attain the same level of intravascular volume
expansion.
There were some limitations to our study.
Hemodynamic variables were derived noninvasively
using the volume clamp method. There are conflicting
reports on the agreement of this measurement method with
CO measurements derived from reference methods.8,24-28
Therefore, an important limitation of the current study is
the absence of a gold standard technique for measuring CO.
Table 2 A-B Specification of the number of responders / non-
responders, grey zone (= area of uncertainty) limits, and percentage of
patients within these limits for PPV (A) and SVV (B)
:SVI (%)
threshold
No. of
responders
and non-
responders
Limits of
the grey
zone (%)
Percentage of
patients below/
within/above
grey zone
A: PVV
10 56/25 9-16 21 / 48 / 31
15 34/47 10-16 28 / 41 / 31
20 22/59 14-17 54 / 17 / 29
25 16/65 18-21 72 / 7 / 21
B: SVV
10 56/25 5-13 11 / 53 / 36
15 34/47 7-14 18 / 51 / 31
20 22/59 10-15 49 / 22 / 29
25 16/65 14-16 69 / 6 / 25
Data are given for each definition of minimal relative increase in
stroke volume index (:SVI) for A: pulse pressure variation (PPV) and
B: stroke volume variation (SVV)
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Most of the negative reports24,25 involved patient
populations that differed from ours, that is, these other
studies focused on ‘‘sicker’’ patients who were admitted to
the intensive care unit and mostly required vasopressor
support or patients who had just been weaned from
cardiopulmonary bypass during cardiac surgery. In
contrast, while it was the clinical decision of the
attending anesthesiologist to administer colloids, we
studied patients in an otherwise relatively stable
hemodynamic phase. Also, we used only relative changes
in SVI to define FR. We therefore expect that the possible
influence of measurement bias on the observed results is
substantially reduced.29 Nevertheless, the current results
should be interpreted with caution because of possible
inaccuracy in measuring SVI using the applied
measurement method. This might by itself explain some
degree of difference between the subgroups of SVI
thresholds. Therefore, future studies require the
application of more validated measurement methods to
confirm the current results. In addition, future studies
should also assess the influence of cardiac function, as we
did not perform a prospective evaluation of cardiac
function in this study; consequently, the degree to which
our conclusions are applicable in patients with varying
levels of cardiac dysfunction is unclear.
A further limitation is the fact that the FR and dynamic
variables we studied were both determined from the same
signal, which might lead to mathematical coupling of the
investigated variables. Ideally, CO data should have been
obtained using an alternative independent approach.
Furthermore, we did not compare noninvasively derived PPV
and SVV measurements with invasively derived dynamic
variables. Yet, we have previously shown that invasive and
noninvasive dynamic variables have a similar ability to predict
FR.9 In addition, two reports10,28 have shown that dynamic
variables derived by the volume clamp method are closely
correlated with dynamic variables measured invasively before
and after volume loading in post-cardiac surgical patients.
Nevertheless, it was recently suggested that invasive variables
may still provide the best ability to predict FR.30
In four (4.4%) out of 90 patients, we could not derive an
adequate waveform quality by the volume clamp method,
which is a limitation of this noninvasive technique. Finally,
dynamic variables can reliably predict FR only if certain
clinical conditions are met, e.g., sinus rhythm, volume-
controlled mechanical ventilation with tidal volumes C 8
mLkg-1 in closed-chest conditions.31 Unfortunately, it has
been previously shown that, when considering all patients
presenting for any type of surgery and any form of
anesthesia, a valid interpretation of FR using dynamic
variables is possible in only 39% of cases.31,32
Nevertheless, all our included patients met the required
clinical criteria, assuring that PPV and SVV allowed a
valid interpretation of FR.
In conclusion, the ability of PPV and SVV values
derived by the noninvasive volume clamp method to
predict FR was adequate at all investigated :SVI
thresholds, although with increasing thresholds, their
ability similarly increases and grey zone limits narrow.
Future studies should apply reference methods of
measuring SVI to validate these results. Nevertheless,
before a final decision can be made whether or not to
administer fluids, the current data suggest that absolute
values of dynamic variables should not be the only
consideration. The intended increase in CO as well as
patient comorbidity and patient-specific risk factors
regarding fluid-related risks for hypo- or hypervolemia
should also be considered for assessing FR.
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